These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8757618

  • 1. Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors.
    Xia M, Gaufo GO, Wang Q, Sreedharan SP, Goetzl EJ.
    J Immunol; 1996 Aug 01; 157(3):1132-8. PubMed ID: 8757618
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane.
    Xia M, Leppert D, Hauser SL, Sreedharan SP, Nelson PJ, Krensky AM, Goetzl EJ.
    J Immunol; 1996 Jan 01; 156(1):160-7. PubMed ID: 8598457
    [Abstract] [Full Text] [Related]

  • 4. T cell vasoactive intestinal peptide receptor subtype expression differs between granulomas and spleen of schistosome-infected mice.
    Metwali A, Elliott D, Blum AM, Li J, Sandor M, Weinstock JV.
    J Immunol; 1996 Jul 01; 157(1):265-70. PubMed ID: 8683124
    [Abstract] [Full Text] [Related]

  • 5. Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses.
    Goetzl EJ, Pankhaniya RR, Gaufo GO, Mu Y, Xia M, Sreedharan SP.
    Ann N Y Acad Sci; 1998 May 01; 840():540-50. PubMed ID: 9629281
    [Abstract] [Full Text] [Related]

  • 6. Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis.
    Schratzberger P, Geiseler A, Dunzendorfer S, Reinisch N, Kähler CM, Wiedermann CJ.
    J Neuroimmunol; 1998 Jul 01; 87(1-2):73-81. PubMed ID: 9670847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug 01; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 13. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S, Pineau N, Becq-Giraudon L, Gressens P, Muller JM, Janet T.
    J Neuroimmunol; 2005 Jan 01; 158(1-2):94-105. PubMed ID: 15589042
    [Abstract] [Full Text] [Related]

  • 14. Vasoactive intestinal peptide enhancement of antigen-induced differentiation of a cultured line of mouse thymocytes.
    Pankhaniya R, Jabrane-Ferrat N, Gaufo GO, Sreedharan SP, Dazin P, Kaye J, Goetzl EJ.
    FASEB J; 1998 Jan 01; 12(1):119-27. PubMed ID: 9438417
    [Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 17. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D, Ribeiro JA, Sebastião AM.
    Brain Res; 2005 Jul 05; 1049(1):52-60. PubMed ID: 15935995
    [Abstract] [Full Text] [Related]

  • 18. [Effects of vasoactive intestinal peptide on chemotaxis of bronchial epithelial cells].
    Guan CX, Zhang CQ, Qin XQ, Luo ZQ, Zhou FW, Sun XH.
    Sheng Li Xue Bao; 2002 Apr 25; 54(2):103-6. PubMed ID: 11973586
    [Abstract] [Full Text] [Related]

  • 19. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.
    J Endocrinol; 2006 Oct 25; 191(1):287-99. PubMed ID: 17065411
    [Abstract] [Full Text] [Related]

  • 20. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR, Henning RJ, Cuevas J, Dehaven WI, Vesely DL.
    Neuropeptides; 2004 Oct 25; 38(5):289-97. PubMed ID: 15464194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.